![124 RANDOMIZED PHASE II CLINICAL TRIAL OF INTRATUMORAL INJECTION OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH HEPATOCELLULAR CARCINOMA]()
124 RANDOMIZED PHASE II CLINICAL TRIAL OF INTRATUMORAL INJECTION OF JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IN PATIENTS WITH HEPATOCELLULAR CARCINOMAJ. Heo; T. Reid; H.Y. Lim; L. Ruo; C.W. Kim; M. Bloomston; H.C. Chung; B.G. Rhee; R. Patt; C.J. Breitbach; T. Hickman; J.C. Bell; T.H. Hwang; D.H. Kirn · 2010